After the historic cancer vaccine met key goals in Phase 3 trials...

Moderna's stock doubled in a single day. And Merck soared too.

(Click below for the stock that could be next...)

According to a tech expert who helped manage $200 million for billionaire Steve Cohen's fund (owner of the New York Mets)... and who's personally met Elon Musk... the biotech stock that could soar next is NOT Moderna, Merck, or any stock you might expect.

The #1 play right now is a very different kind of company – directly tied into this story.

It holds the key to a new tech that could make Moderna and Merck's accomplishment look small by comparison...

This tech:

• Is already backed by billionaires Elon Musk, Sam Altman, Jeff Bezos, and Peter Thiel.
• Nvidia CEO Jensen Huang says it's about to have "the most dramatic impact" on our lives.
• Anthropic's CEO says it could unlock 100 years of medical progress in the next 10 years alone.
• And its impact on our health could be so dramatic... Nature Magazine says it could be worth $367 trillion to the global economy.

This new medical tech is already going live across the United States.

Before you wake up to the next big biotech gain – and miss out...

Click "Yes, Tell Me More!" below to learn about the top way to play this new era of biotech and medicine.

Move your money as soon as possible.

That is the urgent message from Larry Benedict, the trader who generated $274 million in profits for his clients.

You see, every time the Federal Reserve makes a major move, certain assets move with it, and if you're positioned correctly, the returns can be extraordinary.

When the Fed cut rates in 2020, Larry's readers had the chance to make 62% from a single position. 

When it signaled rate hikes in January 2022, they could have made 117% in under a month. 

When Fed Chair Jerome Powell spoke at Jackson Hole, Larry had his readers positioned for an 89% gain in just 17 days.

Now, President Trump is installing a new Fed chair and Larry says it's triggering what could be the most significant shift in the U.S. financial system in nearly 20 years.

He has already identified the single ticker he says will be at the center of where the money flows.

Click "Yes, Tell Me More!" below to discover the one move Larry is recommending now.

Trump fired a warning shot.

And buried inside that political fight is one of the most mispriced energy stocks I’ve seen in years.

I’m not talking about Exxon.

Not Chevron.

Not some crowded AI darling trading at 80 times earnings.

I’m talking about one obscure American energy company sitting at the crossroads of AI, natural gas, and the biggest power crisis in decades.

Here’s why I’m so aggressive on it...

This company generated roughly $3.2 billion in operating income.

Yet the entire business is valued at around $8 billion.

That is crazy cheap.

Especially when you consider that Wall Street is already moving in.

Institutions own a huge percentage of the shares.

BlackRock is in.

Vanguard is in.

A top value investor nearly doubled down.

And still, most investors have no idea what this company is.

That’s exactly the kind of setup I look for.

Huge profits.

Cheap valuation.

A real catalyst.

And almost no mainstream attention.

I call it my Ultimate Stock Unicorn.

Because after screening 23,281 publicly traded companies, only one passed my criteria.

One.

I believe this stock could become one of the biggest surprises in the market as AI’s energy demand explodes.

Click "Yes, Tell Me More!" below to see the name, ticker, and full story behind my Ultimate Stock Unicorn.